Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ashton

Showing results (21-30 of 248) with videos related to

Pageof 25
Sort By:
The New Zealand Medical Journal|August 22, 2024
The case for publicly funding lorlatinibJohn C Ashton
Biochemical Pharmacology|August 10, 2025
ALK inhibitors against resistance in non-small cell lung cancer: an 18 year medical arms raceJ C Ashton
Medical Hypotheses|February 21, 2012
Neuropathic pain: an evolutionary hypothesisJohn C Ashton
Current Drug Discovery Technologies|July 31, 2013
Phylogenetic methods in drug discoveryJohn C Ashton
Cancer Research|May 16, 2015
Drug combination studies and their synergy quantification using the Chou-Talalay method--letterJohn C Ashton
Hippocampus|May 4, 2011
The use of knockout mice to test the specificity of antibodies for cannabinoid receptorsJohn C Ashton
British Journal of Pharmacology|June 29, 2011
Knockout controls and the specificity of cannabinoid CB2 receptor antibodiesJohn C Ashton
Behavioural Processes|December 2, 2014
Hogan's framework for the study of behavior as applied to personality psychologyMichael C Ashton
Central Nervous System Agents in Medicinal Chemistry|July 27, 2012
The atypical cannabinoid O-1602: targets, actions, and the central nervous systemJohn C Ashton
Medical Hypotheses|October 22, 2019
A radical hypothesis on the nature of sleepJohn C Ashton
Pageof 25

Showing results (21-30 of 248) with videos related to

Sort By:
Pageof 25
The New Zealand Medical Journal|August 22, 2024
The case for publicly funding lorlatinibJohn C Ashton
Biochemical Pharmacology|August 10, 2025
ALK inhibitors against resistance in non-small cell lung cancer: an 18 year medical arms raceJ C Ashton
Medical Hypotheses|February 21, 2012
Neuropathic pain: an evolutionary hypothesisJohn C Ashton
Current Drug Discovery Technologies|July 31, 2013
Phylogenetic methods in drug discoveryJohn C Ashton
Cancer Research|May 16, 2015
Drug combination studies and their synergy quantification using the Chou-Talalay method--letterJohn C Ashton
Hippocampus|May 4, 2011
The use of knockout mice to test the specificity of antibodies for cannabinoid receptorsJohn C Ashton
British Journal of Pharmacology|June 29, 2011
Knockout controls and the specificity of cannabinoid CB2 receptor antibodiesJohn C Ashton
Behavioural Processes|December 2, 2014
Hogan's framework for the study of behavior as applied to personality psychologyMichael C Ashton
Central Nervous System Agents in Medicinal Chemistry|July 27, 2012
The atypical cannabinoid O-1602: targets, actions, and the central nervous systemJohn C Ashton
Medical Hypotheses|October 22, 2019
A radical hypothesis on the nature of sleepJohn C Ashton
Pageof 25